Skip to main content
. 2017 Jun 12;17:68. doi: 10.1186/s12893-017-0265-3

Table 1.

Comparison of the clinicopathological differences between minimally invasive gastrectomy and open gastrectomy for octogenarian and older gastric cancer patients

Minimally invasive gastrectomy n = 27 Open gastrectomy n = 53 P value
Age (years) 84.3 ± 3.3 84.1 ± 3.2 0.831
Gender (M/F) 19/8 41/12 0.587
Tumor size (cm) 3.9 ± 2.3 4.3 ± 2.5 0.478
BMI (kg/m2) 24.4 ± 3.1 22.7 ± 3.5 0.032
Resection extent 0.015
Subtotal/total gastrectomy 26/1 39/14
Reconstruction method 0.345
Billroth-I 6 (22.2) 7 (13.2)
Roux-en-Y or uncut R-Y 21 (77.8) 46 (86.8)
Extent of lymphadenectomy
<D2/D2 2/25 6/47 0.710
Retrieved LN number 26.0 ± 10.1 28.4 ± 13.4 0.428
Pathological T category 0.017
T1/T2/T3/T4 17/3/6/1 17/12/17/7
Pathological N category 0.058
N0/N1/N2/N3 20/2/4/1 29/4/12/8
Pathological TNM stage 0.051
I/II/III 18/6/3 22/13/18
Number of comorbidities 0.363
0 5 (18.5) 9 (17)
1 6 (22.2) 22 (41.5)
≧2 16 (59.3) 22 (41.5)
Operative outcomes
Operative time (min) 311.5 ± 106.6 313.2 ± 101.9 0.945
Operative blood loss (mL) 63.7 ± 59.2 372.3 ± 340.4 <0.001
Postoperative hospital stay (day) 10.7 ± 8.6 15.4 ± 9.7 0.036
Surgical complications 6 (22.2) 6 (11.3) 0.207
Anastomosis leakage 1 (3.7) 1 (1.9) 1.000
Anastomosis stenosis 1 (3.7) 0 0.337
Delayed gastric emptying 4 (14.8) 2 (3.8) 0.172
Intestinal obstruction 1 (3.7) 0 0.337
Pneumonia 0 2 (3.8) 0.547
Surgical Mortality 0 1 (1.9) 1.000

BMI: body mass index; LN: lymph node; comorbidities including cardiovascular disease, cerebrovascular accident, endocrine disease, pulmonary disease, liver cirrhosis, benign prostate hyperplasia, etc.

Some patients had more than one complication

Data were presented as mean ± SD or n (%)